Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations-Reference-Cited by-同舟云学术

Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations

Published:2023-05 Issue:5 Volume:41 Page:252.e9-252.e17
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Nguyen David-Dan^ORCID,Labban Muhieddine,Briggs Logan,Wallis Christopher J.D.,Cole Alexander P.,Lipsitz Stuart R.,Iyer Hari S.,Rebbeck Timothy R.,Weissman Joel S.,Choueiri Toni K.,Trinh Quoc-Dien^ORCID

Funder

American Cancer Society

Pfizer

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference30 articles.

1. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups;Mahal;Urology,2014

2. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts;Cole;Cancer,2021

3. Racial differences in medical mistrust among men diagnosed with prostate cancer;Halbert;Cancer,2009

4. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years;Fletcher;Cancer,2020

5. Association of care at minority-serving vs non-minority-serving hospitals with use of palliative care among racial/ethnic minorities with metastatic cancer in the United States;Cole;JAMA Netw Open,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color;Journal of Urology;2024-07

2. A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in Massachusetts;Cancer;2024-06-04

3. Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers;Cancer;2024-05-27

4. Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden;Scandinavian Journal of Urology;2023-11-09

5. Prostate cancer screening in African American men: a review of the evidence;JNCI: Journal of the National Cancer Institute;2023-09-15